Arrhythmogenic Substrates for Atrial Fibrillation in Obesity

Global obesity rates have nearly tripled since 1975. This obesity rate increase is mirrored by increases in atrial fibrillation (AF) that now impacts nearly 10% of Americans over the age of 65. Numerous epidemiologic studies have linked incidence of AF and obesity and other obesity-related diseases,...

Full description

Bibliographic Details
Main Authors: Ellen R. Lubbers, Morgan V. Price, Peter J. Mohler
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2018.01482/full
id doaj-cb208821c8cc424d94ac027de5a7832d
record_format Article
spelling doaj-cb208821c8cc424d94ac027de5a7832d2020-11-24T21:15:24ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2018-10-01910.3389/fphys.2018.01482416524Arrhythmogenic Substrates for Atrial Fibrillation in ObesityEllen R. Lubbers0Ellen R. Lubbers1Morgan V. Price2Peter J. Mohler3Peter J. Mohler4Peter J. Mohler5The Dorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, United StatesMedical Scientist Training Program, The Ohio State University Wexner Medical Center, Columbus, OH, United StatesThe Dorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, United StatesThe Dorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, United StatesDepartment of Physiology & Cell Biology, The Ohio State University Wexner Medical Center, Columbus, OH, United StatesDepartment of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United StatesGlobal obesity rates have nearly tripled since 1975. This obesity rate increase is mirrored by increases in atrial fibrillation (AF) that now impacts nearly 10% of Americans over the age of 65. Numerous epidemiologic studies have linked incidence of AF and obesity and other obesity-related diseases, including hypertension and diabetes. Due to the wealth of epidemiologic data linking AF with obesity-related disease, mechanisms of AF pathogenesis in the context of obesity are an area of ongoing investigation. However, progress has been somewhat slowed by the complex phenotype of obesity; separating the effects of obesity from those of related sequelae is problematic. While the initiation of pathogenic pathways leading to AF varies with disease (including increased glycosylation in diabetes, increased renin angiotensin aldosterone system activation in hypertension, atrial ischemia in coronary artery disease, and sleep apnea) the pathogenesis of AF is united by shared mediators of altered conduction in the atria. We suggest focusing on these downstream mediators of AF in obesity is likely to yield more broadly applicable data. In the context of obesity, AF is driven by the interrelated processes of inflammation, atrial remodeling, and oxidative stress. Obesity is characterized by a constant low-grade inflammation that leads to increased expression of pro-inflammatory cytokines. These cytokines contribute to changes in cardiomyocyte excitability. Atrial structural remodeling, including fibrosis, enlargement, and fatty infiltration is a prominent feature of AF and contributes to the altered conduction. Finally, obesity impacts oxidative stress. Within the cardiomyocyte, oxidative stress is increased through both increased production of reactive oxygen species and by downregulation of scavenging enzymes. This increased oxidative stress modulates of cardiomyocyte excitability, increasing susceptibility to AF. Although the initiating insults vary, inflammation, atrial remodeling, and oxidative stress are conserved mechanisms in the pathophysiology of AF in the obese patients. In this review, we highlight mechanisms that have been shown to be relevant in the pathogenesis of AF across obesity-related disease.https://www.frontiersin.org/article/10.3389/fphys.2018.01482/fullobesityarrhythmiaatrial fibrillationinflammationremodelingoxidative stress
collection DOAJ
language English
format Article
sources DOAJ
author Ellen R. Lubbers
Ellen R. Lubbers
Morgan V. Price
Peter J. Mohler
Peter J. Mohler
Peter J. Mohler
spellingShingle Ellen R. Lubbers
Ellen R. Lubbers
Morgan V. Price
Peter J. Mohler
Peter J. Mohler
Peter J. Mohler
Arrhythmogenic Substrates for Atrial Fibrillation in Obesity
Frontiers in Physiology
obesity
arrhythmia
atrial fibrillation
inflammation
remodeling
oxidative stress
author_facet Ellen R. Lubbers
Ellen R. Lubbers
Morgan V. Price
Peter J. Mohler
Peter J. Mohler
Peter J. Mohler
author_sort Ellen R. Lubbers
title Arrhythmogenic Substrates for Atrial Fibrillation in Obesity
title_short Arrhythmogenic Substrates for Atrial Fibrillation in Obesity
title_full Arrhythmogenic Substrates for Atrial Fibrillation in Obesity
title_fullStr Arrhythmogenic Substrates for Atrial Fibrillation in Obesity
title_full_unstemmed Arrhythmogenic Substrates for Atrial Fibrillation in Obesity
title_sort arrhythmogenic substrates for atrial fibrillation in obesity
publisher Frontiers Media S.A.
series Frontiers in Physiology
issn 1664-042X
publishDate 2018-10-01
description Global obesity rates have nearly tripled since 1975. This obesity rate increase is mirrored by increases in atrial fibrillation (AF) that now impacts nearly 10% of Americans over the age of 65. Numerous epidemiologic studies have linked incidence of AF and obesity and other obesity-related diseases, including hypertension and diabetes. Due to the wealth of epidemiologic data linking AF with obesity-related disease, mechanisms of AF pathogenesis in the context of obesity are an area of ongoing investigation. However, progress has been somewhat slowed by the complex phenotype of obesity; separating the effects of obesity from those of related sequelae is problematic. While the initiation of pathogenic pathways leading to AF varies with disease (including increased glycosylation in diabetes, increased renin angiotensin aldosterone system activation in hypertension, atrial ischemia in coronary artery disease, and sleep apnea) the pathogenesis of AF is united by shared mediators of altered conduction in the atria. We suggest focusing on these downstream mediators of AF in obesity is likely to yield more broadly applicable data. In the context of obesity, AF is driven by the interrelated processes of inflammation, atrial remodeling, and oxidative stress. Obesity is characterized by a constant low-grade inflammation that leads to increased expression of pro-inflammatory cytokines. These cytokines contribute to changes in cardiomyocyte excitability. Atrial structural remodeling, including fibrosis, enlargement, and fatty infiltration is a prominent feature of AF and contributes to the altered conduction. Finally, obesity impacts oxidative stress. Within the cardiomyocyte, oxidative stress is increased through both increased production of reactive oxygen species and by downregulation of scavenging enzymes. This increased oxidative stress modulates of cardiomyocyte excitability, increasing susceptibility to AF. Although the initiating insults vary, inflammation, atrial remodeling, and oxidative stress are conserved mechanisms in the pathophysiology of AF in the obese patients. In this review, we highlight mechanisms that have been shown to be relevant in the pathogenesis of AF across obesity-related disease.
topic obesity
arrhythmia
atrial fibrillation
inflammation
remodeling
oxidative stress
url https://www.frontiersin.org/article/10.3389/fphys.2018.01482/full
work_keys_str_mv AT ellenrlubbers arrhythmogenicsubstratesforatrialfibrillationinobesity
AT ellenrlubbers arrhythmogenicsubstratesforatrialfibrillationinobesity
AT morganvprice arrhythmogenicsubstratesforatrialfibrillationinobesity
AT peterjmohler arrhythmogenicsubstratesforatrialfibrillationinobesity
AT peterjmohler arrhythmogenicsubstratesforatrialfibrillationinobesity
AT peterjmohler arrhythmogenicsubstratesforatrialfibrillationinobesity
_version_ 1716745389497909248